You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NPC2

Showing 1 - 25 of 444
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

IMRT vs 2DRT for NPC Patients

Completed
  • NPC
  • IMRT
  • 2DRT
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Oct 21, 2021

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • Stanford, California
    Stanford University
Mar 31, 2022

Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Detroit, Michigan
  • +4 more
Jan 31, 2023

Biomarker for Niemann Pick Type C Disease (BioNPC)

Active, not recruiting
  • Niemann-Pick Disease
  • Niemann-Pick Disease, Type C
    • Rostock, Germany
    • +3 more
    May 12, 2021

    Spinal Cord Injury, Acute, Spinal Cord Injury at C4 Level With Complete Lesion, Spinal Cord Injury at C5-C7 Level With Complete

    Recruiting
    • Spinal Cord Injury, Acute
    • +2 more
    • Neural precursor cells derived from human embryonic stem cell line
    • Suwon, Gyeonggido, Korea, Republic of
    • +1 more
    May 3, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Cholesterol metabolism disruption
    • Quebec city, Quebec, Canada
      CHU de Québec-Université Laval
    Oct 17, 2022

    Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8

    Not yet recruiting
    • Stage II Nasopharyngeal Carcinoma AJCC v8
    • +2 more
    • Biopsy
    • +16 more
    • (no location specified)
    Oct 7, 2023

    Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma

    Completed
    Has Results
    • Stage II Lymphoepithelioma of the Nasopharynx
    • +5 more
    • Stanford, California
      Stanford University Hospitals and Clinics
    Mar 10, 2021

    Nasopharyngeal Carcinoma Trial in Guangzhou (GP combine with Tislelizumab neoadjuvant therapy+CCRT)

    Recruiting
    • Nasopharyngeal Carcinoma
    • GP combine with Tislelizumab neoadjuvant therapy+CCRT
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Apr 15, 2021

    Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma Trial in Worldwide (Nanatinostat,

    Recruiting
    • Nasopharyngeal Carcinoma
    • +4 more
    • Lynwood, California
    • +20 more
    Jul 27, 2022

    Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)

    Recruiting
    • Tuberculosis, Pulmonary
    • H56:IC31
    • Placebo
    • Bellville, Cape Town, South Africa
    • +5 more
    Sep 27, 2021

    Niemann-Pick Disease, Type C Trial (VTS-270)

    Withdrawn
    • Niemann-Pick Disease, Type C
    • (no location specified)
    Jul 20, 2020

    Niemann-Pick Disease, Type C Trial in Worldwide (Parts A/B: Adrabetadex, Parts A/B: Sham Control)

    Active, not recruiting
    • Niemann-Pick Disease, Type C
    • Parts A/B: Adrabetadex
    • Parts A/B: Sham Control
    • Birmingham, Alabama
    • +28 more
    Jul 23, 2021

    Environmental and Genetic Determinants of NPC

    Terminated
    • Nasopharyngeal Neoplasms
    • Herpesvirus 4, Human
      • Taipei City, Taiwan
      • +5 more
      Jun 3, 2020

      Bioavailability Study Trial in Miami (NPC-12G Gel 0.2%, Rapamune® 2 mg tablet)

      Completed
      • Bioavailability Study
      • NPC-12G Gel 0.2%
      • Rapamune® 2 mg tablet
      • Miami, Florida
        InVentiv Health Clinical Research Services LLC
      Mar 4, 2020

      Nasopharyngeal Carcinoma Trial in Worldwide (autologous EBV specific Cytotoxic T cells, combination IV gemcitabine and IV

      Active, not recruiting
      • Nasopharyngeal Carcinoma
      • autologous EBV specific Cytotoxic T cells
      • combination IV gemcitabine and IV carboplatin (AUC2)
      • Duarte, California
      • +29 more
      Mar 5, 2021

      Genomic and Phenotypic Database for Niemann-Pick Disease, Type C

      Recruiting
      • Niemann-Pick Disease, Type C
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
        • Singapore, Singapore
        • +1 more
        Oct 16, 2023

        Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • without concurrent cisplatin chemotherapy
        • with concurrent cisplatin chemotherapy
        • Fuzhou, Fujian, China
          Department of radiation oncology, Fujian cancer hospital
        Oct 18, 2023

        Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)

        Recruiting
        • Tuberous Sclerosis Complex
        • NPC-12Y gel
        • NPC-12Y placebo gel
        • Toyoake, Aichi, Japan
        • +4 more
        Aug 8, 2022

        Prostate Cancer Trial in Darlinghurst (SUBA-itraconazole, Hydroxychloroquine)

        Recruiting
        • Prostate Cancer
        • Darlinghurst, New South Wales, Australia
          St Vincent's Hospital
        May 3, 2022

        Tumor Positron-Emission Tomography Trial in Fuzhou (68Ga-DOTATATE and 68Ga-FAPI)

        Recruiting
        • Tumor Positron-Emission Tomography
        • 68Ga-DOTATATE and 68Ga-FAPI
        • Fuzhou, Fujian, China
          Department of Nuclear Medicine, First Affiliated Hospital of Fuj
        Aug 7, 2023

        Concussion, Brain, Near Point Convergence Trial in Pittsburgh (Brock String Therapy, Standard of Care)

        Recruiting
        • Concussion, Brain
        • Near Point Convergence
        • Brock String Therapy
        • Standard of Care
        • Pittsburgh, Pennsylvania
          University of Pittsburgh Medical Center, Rooney Sports Complex
        Jan 17, 2023

        Acute Pain in Herpes Zoster Trial in Japan (NPC-06, Placebo)

        Not yet recruiting
        • Acute Pain in Herpes Zoster
        • Urayasu, Chiba, Japan
        • +19 more
        Jul 29, 2022